About
Ekso Bionics Holdings, Inc. specializes in the design and development of advanced exoskeleton technology that enhances human strength, endurance, and mobility. Founded in 2005 as Berkeley Bionics, the company has evolved from its origins in military applications to focus primarily on medical rehabilitation and industrial markets. Headquartered in the San Francisco Bay Area, Ekso Bionics is publicly traded on NASDAQ under the ticker EKSO. The company offers a range of medical exoskeletons, including the FDA-cleared EksoNR for neurorehabilitation and the EksoGT, which features adaptive software for gait training. Additionally, Ekso Bionics provides industrial exoskeletons like the EksoVest and Ekso EVO, designed to enhance worker endurance and reduce injury risk in physically demanding jobs. With a commitment to innovation, the company continues to develop software enhancements and collaborates with research institutions to advance exoskeleton technology across various applications.
Technologies
Keywords
Company Information
- Employees61
- Founded2005
- Annual Revenue$17925000
- Total Funding$67490000
Location
101 Glacier Pt, San Rafael, California, United States, 94901-5547
